This article first appeared in the Washington Spectator. On April 7, U.S. district judge Matthew Kacsmaryk made headlines with an unprecedented ruling suspending the 2000 FDA approval of the abortion medication mifepristone. The ruling marked the first time a court has tried to invalidate the approval of a medication over the objection of the FDA. Within an hour of Kacsmaryk’s ruling...
